Ownership history in CITIGROUP INC · 22 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in ZENTALIS PHARMACEUTICALS INC (ZNTL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 906 | -18,541 | -95.3% | 0.00% | $1K | $1.51 |
| 2025 Q2 | REDUCED | 19,447 | -21,199 | -52.2% | 0.00% | $23K | $1.16 |
| 2025 Q1 | REDUCED | 40,646 | -4,855 | -10.7% | 0.00% | $65K | $1.59 |
| 2024 Q4 | ADDED | 45,501 | +1,815 | +4.2% | 0.00% | $138K | $3.03 |
| 2024 Q3 | REDUCED | 43,686 | -240 | -0.5% | 0.00% | $161K | $3.68 |
| 2024 Q2 | REDUCED | 43,926 | -213,161 | -82.9% | 0.00% | $180K | $4.09 |
| 2024 Q1 | ADDED | 257,087 | +111,169 | +76.2% | 0.00% | $4.1M | $15.76 |
| 2023 Q4 | ADDED | 145,918 | +60,713 | +71.3% | 0.00% | $2.2M | $15.15 |
| 2023 Q3 | REDUCED | 85,205 | -202 | -0.2% | 0.00% | $1.7M | $20.06 |
| 2023 Q2 | REDUCED | 85,407 | -103,312 | -54.7% | 0.00% | $2.4M | $28.21 |
As of 2025 Q4 — sorted by position size